Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / TLPH - Talphera outlines 2025 timeline for NEPHRO CRRT study completion and FDA approval of Niyad

TLPH - Talphera outlines 2025 timeline for NEPHRO CRRT study completion and FDA approval of Niyad

Talphera Inc.

2025-03-31 18:34:45 ET

More on AcelRx Pharmaceuticals

For further details see:

Talphera outlines 2025 timeline for NEPHRO CRRT study completion and FDA approval of Niyad

Stock Information
Company Name: Talphera Inc.
Stock Symbol: TLPH
Market: NASDAQ
Website: acelrx.com
Menu
TLPH TLPH Quote TLPH Short TLPH News TLPH Articles TLPH Message Board
Get TLPH Alerts

News, Short Squeeze, Breakout and More Instantly...